Novo Nordisk reported DKK33.76B in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Bausch Health Companies USD 993M 217M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Eli Lilly USD 13.09B 635M Sep/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Merck USD 7.33B 6.49B Sep/2026
Novartis USD 5.14B 411M Sep/2026
Novo Nordisk DKK 33.76B 25.86B Jun/2026
Novo Nordisk DKK 5.25B 60.42B Jun/2026
Pacira USD 2.57B 2.56B Sep/2026
Sanofi EUR 4.72B 3.6B Sep/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026